Correction: The chemoprotective effect of anti-platelet agents on cancer incidence in people with non-alcoholic fatty liver disease (NAFLD): a retrospective cohort study
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-03-01
|
| Series: | BMC Medicine |
| Online Access: | https://doi.org/10.1186/s12916-025-04033-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849734830673100800 |
|---|---|
| author | Matthew Anson Jun Shang Poon Alex E. Henney David Riley Gema H. Ibarbaru Cyril Sieberhagen Daniel J. Cuthbertson Uazman Alam Theresa Hydes |
| author_facet | Matthew Anson Jun Shang Poon Alex E. Henney David Riley Gema H. Ibarbaru Cyril Sieberhagen Daniel J. Cuthbertson Uazman Alam Theresa Hydes |
| author_sort | Matthew Anson |
| collection | DOAJ |
| format | Article |
| id | doaj-art-daae75e77b344e21ac148147f1b46bb7 |
| institution | DOAJ |
| issn | 1741-7015 |
| language | English |
| publishDate | 2025-03-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Medicine |
| spelling | doaj-art-daae75e77b344e21ac148147f1b46bb72025-08-20T03:07:41ZengBMCBMC Medicine1741-70152025-03-012311210.1186/s12916-025-04033-xCorrection: The chemoprotective effect of anti-platelet agents on cancer incidence in people with non-alcoholic fatty liver disease (NAFLD): a retrospective cohort studyMatthew Anson0Jun Shang Poon1Alex E. Henney2David Riley3Gema H. Ibarbaru4Cyril Sieberhagen5Daniel J. Cuthbertson6Uazman Alam7Theresa Hydes8Department of Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of LiverpoolUniversity Hospital Aintree, Liverpool University Hospitals NHS Foundation TrustDepartment of Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of LiverpoolDepartment of Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of LiverpoolTriNetX LLCUniversity Hospital Aintree, Liverpool University Hospitals NHS Foundation TrustDepartment of Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of LiverpoolDepartment of Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of LiverpoolDepartment of Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of Liverpoolhttps://doi.org/10.1186/s12916-025-04033-x |
| spellingShingle | Matthew Anson Jun Shang Poon Alex E. Henney David Riley Gema H. Ibarbaru Cyril Sieberhagen Daniel J. Cuthbertson Uazman Alam Theresa Hydes Correction: The chemoprotective effect of anti-platelet agents on cancer incidence in people with non-alcoholic fatty liver disease (NAFLD): a retrospective cohort study BMC Medicine |
| title | Correction: The chemoprotective effect of anti-platelet agents on cancer incidence in people with non-alcoholic fatty liver disease (NAFLD): a retrospective cohort study |
| title_full | Correction: The chemoprotective effect of anti-platelet agents on cancer incidence in people with non-alcoholic fatty liver disease (NAFLD): a retrospective cohort study |
| title_fullStr | Correction: The chemoprotective effect of anti-platelet agents on cancer incidence in people with non-alcoholic fatty liver disease (NAFLD): a retrospective cohort study |
| title_full_unstemmed | Correction: The chemoprotective effect of anti-platelet agents on cancer incidence in people with non-alcoholic fatty liver disease (NAFLD): a retrospective cohort study |
| title_short | Correction: The chemoprotective effect of anti-platelet agents on cancer incidence in people with non-alcoholic fatty liver disease (NAFLD): a retrospective cohort study |
| title_sort | correction the chemoprotective effect of anti platelet agents on cancer incidence in people with non alcoholic fatty liver disease nafld a retrospective cohort study |
| url | https://doi.org/10.1186/s12916-025-04033-x |
| work_keys_str_mv | AT matthewanson correctionthechemoprotectiveeffectofantiplateletagentsoncancerincidenceinpeoplewithnonalcoholicfattyliverdiseasenafldaretrospectivecohortstudy AT junshangpoon correctionthechemoprotectiveeffectofantiplateletagentsoncancerincidenceinpeoplewithnonalcoholicfattyliverdiseasenafldaretrospectivecohortstudy AT alexehenney correctionthechemoprotectiveeffectofantiplateletagentsoncancerincidenceinpeoplewithnonalcoholicfattyliverdiseasenafldaretrospectivecohortstudy AT davidriley correctionthechemoprotectiveeffectofantiplateletagentsoncancerincidenceinpeoplewithnonalcoholicfattyliverdiseasenafldaretrospectivecohortstudy AT gemahibarbaru correctionthechemoprotectiveeffectofantiplateletagentsoncancerincidenceinpeoplewithnonalcoholicfattyliverdiseasenafldaretrospectivecohortstudy AT cyrilsieberhagen correctionthechemoprotectiveeffectofantiplateletagentsoncancerincidenceinpeoplewithnonalcoholicfattyliverdiseasenafldaretrospectivecohortstudy AT danieljcuthbertson correctionthechemoprotectiveeffectofantiplateletagentsoncancerincidenceinpeoplewithnonalcoholicfattyliverdiseasenafldaretrospectivecohortstudy AT uazmanalam correctionthechemoprotectiveeffectofantiplateletagentsoncancerincidenceinpeoplewithnonalcoholicfattyliverdiseasenafldaretrospectivecohortstudy AT theresahydes correctionthechemoprotectiveeffectofantiplateletagentsoncancerincidenceinpeoplewithnonalcoholicfattyliverdiseasenafldaretrospectivecohortstudy |